304 related articles for article (PubMed ID: 37895868)
1. An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine.
Pande LJ; Arnet RE; Piper BJ
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895868
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active.
Brown SM; Holtzman M; Kim T; Kharasch ED
Anesthesiology; 2011 Dec; 115(6):1251-60. PubMed ID: 22037640
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine-Clinically useful but often misunderstood.
Butler S
Scand J Pain; 2013 Jul; 4(3):148-152. PubMed ID: 29913911
[TBL] [Abstract][Full Text] [Related]
4. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain.
Gudin J; Fudin J
Pain Ther; 2020 Jun; 9(1):41-54. PubMed ID: 31994020
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine: new pharmacological aspects.
Cowan A
Int J Clin Pract Suppl; 2003 Feb; (133):3-8; discussion 23-4. PubMed ID: 12665117
[TBL] [Abstract][Full Text] [Related]
6. Continuous Perioperative Sublingual Buprenorphine.
Silva MJ; Rubinstein A
J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):289-293. PubMed ID: 27736284
[TBL] [Abstract][Full Text] [Related]
7. The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder.
De Aquino JP; Parida S; Sofuoglu M
Clin Drug Investig; 2021 May; 41(5):425-436. PubMed ID: 33818748
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.
Huang P; Kehner GB; Cowan A; Liu-Chen LY
J Pharmacol Exp Ther; 2001 May; 297(2):688-95. PubMed ID: 11303059
[TBL] [Abstract][Full Text] [Related]
9. Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats.
Janganati V; Salazar P; Parks BJ; Gorman GS; Prather PL; Peterson EC; Alund AW; Moran JH; Crooks PA; Brents LK
Front Pharmacol; 2023; 14():1123261. PubMed ID: 37229250
[No Abstract] [Full Text] [Related]
10. Buprenorphine: prospective novel therapy for depression and PTSD.
Madison CA; Eitan S
Psychol Med; 2020 Apr; 50(6):881-893. PubMed ID: 32204739
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction.
Robinson SE
CNS Drug Rev; 2002; 8(4):377-90. PubMed ID: 12481193
[TBL] [Abstract][Full Text] [Related]
12. Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation.
Coluzzi F; Rullo L; Scerpa MS; Losapio LM; Rocco M; Billeci D; Candeletti S; Romualdi P
CNS Drugs; 2022 Jun; 36(6):617-632. PubMed ID: 35616826
[TBL] [Abstract][Full Text] [Related]
13. BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.
Khroyan TV; Wu J; Polgar WE; Cami-Kobeci G; Fotaki N; Husbands SM; Toll L
Br J Pharmacol; 2015 Jan; 172(2):668-80. PubMed ID: 24903063
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphine.
Cami-Kobeci G; Polgar WE; Khroyan TV; Toll L; Husbands SM
J Med Chem; 2011 Oct; 54(19):6531-7. PubMed ID: 21866885
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine Use for Analgesia in Palliative Care.
Jackson LK; Poon IO; Garcia MA; Imam S; Braun UK
Pharmacy (Basel); 2024 May; 12(3):. PubMed ID: 38804470
[TBL] [Abstract][Full Text] [Related]
16. Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats.
Burke NN; Ferdousi M; Deaver DR; Finn DP; Roche M; Kelly JP
Neuropharmacology; 2019 Mar; 146():327-336. PubMed ID: 30553825
[TBL] [Abstract][Full Text] [Related]
17. Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation.
Ling W; Shoptaw S; Goodman-Meza D
Subst Abuse Rehabil; 2019; 10():69-78. PubMed ID: 31819701
[TBL] [Abstract][Full Text] [Related]
18. The history and pharmacology of buprenorphine: New advances in cats.
Clark TP
J Vet Pharmacol Ther; 2022 Jul; 45 Suppl 1():S1-S30. PubMed ID: 35790013
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder.
Namchuk AB; Lucki I; Browne CA
Adv Drug Alcohol Res; 2022; 2():. PubMed ID: 36177442
[TBL] [Abstract][Full Text] [Related]
20. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
Cisewski DH; Santos C; Koyfman A; Long B
Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
